Daily Focus: HMG (Human Menopausal Gonadotropin) — A Decades-Old Fertility Workhorse Back in the Trial Spotlight
Two newly registered randomized trials, including a large Phase 3 study, are re-examining whether the LH activity in human menopausal gonadotropin improves live-birth and embryo-quality outcomes in IVF.
Source: ClinicalTrials.gov — GRACE hMG Phase 3 Trial
Amycretin Heads Into Late-Stage Testing as Novo Bets on a Single Amylin/GLP-1 Peptide
Novo Nordisk is advancing injectable and oral amycretin, one peptide that activates both GLP-1 and amylin receptors, into Phase 3 programs for obesity and type 2 diabetes.
Source: Fierce Biotech — Amycretin Phase 3 Plans
Icotrokinra Shows Oral Peptides Can Compete With Injectable Biologics in Psoriasis
Johnson & Johnson's IL-23 receptor-blocking oral peptide Icotyde, approved this spring, is emerging as a template for pill-form alternatives to antibody therapies.
Source: Healio — Icotrokinra FDA Approval
Independent Replication Supports Epitalon's Telomerase Activation in Human Cell Models
A 2025 Biogerontology study replicated the central laboratory finding that the AEDG tetrapeptide extends telomere length in cultured human cells, keeping Epitalon on the longevity research map even as clinical evidence lags.
Source: Yahoo Finance Healthcare
BPC-157 Clinical Evidence Base Remains Thin Despite Advisory Vote and Growing Patient Use
An FDA scientific review of BPC-157 found that only five human trials existed, all short in duration and small in sample size, highlighting a widening gap between booming consumer demand and genuine clinical data.
Source: PMC — Pharmaceuticals Commentary 2026
Retatrutide TRIUMPH-1 Phase 3 Reports Average 30% Weight Loss at 104 Weeks
Eli Lilly's triple-agonist retatrutide produced an average 30.3% body-weight reduction at the 12 mg dose in the 2,339-participant TRIUMPH-1 obesity trial, setting a new benchmark for incretin therapy.
Source: AJMC
Daily Focus: HGH Fragment 176-191 — The Lipolytic Tail With Beta-3 Receptor Dependence
Fresh 2026 reviews of HGH Fragment 176-191 confirm its direct lipolytic action on adipocytes but highlight the stark divide between preclinical fat-loss data and the near-total absence of human trial evidence.
Source: HGH Fragment 176-191 Research Overview
GLP-1 Drugs Show Promise for Addiction Treatment in Emerging Research
Harvard researchers outline expanding clinical applications for GLP-1 peptides beyond weight loss, including early evidence of reduced cravings in substance use disorders.
Source: Harvard Gazette
Mitochondrial Peptides Emerge as Major Research Category in 2026
MOTS-C and humanin are moving from niche curiosities to recognized research targets, with new studies exploring their roles in aging, metabolism, and exercise mimicry.
Source: Alpha Peptides
Novartis Wins Expanded FDA Approval for Peptide-Based Prostate Cancer Therapy Pluvicto
Pluvicto (lutetium-177 vipivotide tetraxetan) receives expanded approval for use before chemotherapy in metastatic prostate cancer, showing a 28% reduction in disease progression risk.
Source: Peptide Protocol Wiki
Genetic Study Reveals 10% of Population May Be Resistant to GLP-1 Diabetes Drugs
Stanford researchers have identified genetic variants carried by roughly one in ten people that significantly reduce the effectiveness of GLP-1 receptor agonists for blood sugar control.
Source: Stanford Medicine
Eli Lilly's Retatrutide Delivers Record 71-Pound Average Weight Loss in Phase 3 Trial
The triple-agonist peptide retatrutide achieved unprecedented weight loss in the TRIUMPH-4 trial while also providing substantial relief from osteoarthritis knee pain.
Source: Eli Lilly Investor Relations
Stanford Researchers Discover BRP Peptide — A Potential Side-Effect-Free Alternative to Ozempic
Stanford scientists have identified a novel brain-targeted peptide called BRP that suppresses appetite as effectively as GLP-1 drugs but without nausea or muscle loss in animal models.
Source: ScienceDaily
Daily Briefing
Get the latest peptide research delivered to your inbox every morning.
The Peptide Wizard
High-quality research peptides for lab use. Third-party tested with certificate of analysis available on every product.
Visit The Peptide WizardSponsored content. ThePBrief receives compensation. For research purposes only.